Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer

Proof-of-concept was provided for an electrically conductive and nanoroughened microfluidic platform-based chip designed to capture CTCs in patients with EOC. A larger patient sampling and longer duration of follow-up are needed to determine its suitability for clinical use.